English | Español
Robert Hadley | May 16, 2017

Immunosuppressive drug cladribine may slow progression of MS

Robert Hadley | May 14, 2017

Bristol-Myers Squibb dual-drug treatment for hepatitis C gains China approval
Cheyenne Dickerson | May 11, 2017

European Commission approves Tagrisso for treating non-small cell lung cancer
Robert Hadley | May 11, 2017

NanoViricides says it's close to trials for topical shingles treatment
Erianne Leatherman | May 11, 2017

14 companies warned about falsely marketing cancer products

Carol Ostrow | May 10, 2017

Darzalex granted European Commission approval for multiple myeloma patients
Robert Hadley | May 7, 2017

Physician credentialing eased by quality assurance partnership
Erianne Leatherman | May 7, 2017

'Desktop Medicine' should be covered under patient payment policies, study says

Trending
+ Pharmaceuticals
Patient Daily | Oct 30, 2025

Baylor St. Luke's receives GammaTile Center of Excellence designation for brain tumor care
+ Pharmaceuticals
Patient Daily | Nov 3, 2025

Patient groups urge Congress to renew enhanced premium tax credits before open enrollment
+ Pharmaceuticals
Patient Daily | Oct 29, 2025

Paragon Health Institute senior fellow: 340B program 'needs real reform'
+ Pharmaceuticals
Patient Daily | Oct 30, 2025

Study links higher death rates in veterans’ post-TBI epilepsy